327. Idiopathic thrombosis Disease details / Clinical trials / Drug dev / DR info /
Clinical trials : 3 / Drugs : 13 - (DrugBank : 3) / Drug target gene : 1 - Drug target pathway : 1
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Clexane
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Clexane/lovenox
Academic Medical Center Amsterdam
2018 Phase 3 EUCTR2012-001447-43-AT Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Dalteparin sodium
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Enoxaparin
Academic Medical Center Amsterdam
2018 Phase 3 EUCTR2012-001447-43-AT Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Enoxaparin sodium
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Fragmin
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Innohep
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Tinzaparin sodium
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Clexane/lovenox
Academic Medical Center Amsterdam
2018 Phase 3 EUCTR2012-001447-43-AT Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Dalteparin sodium
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Enoxaparin
Academic Medical Center Amsterdam
2018 Phase 3 EUCTR2012-001447-43-AT Austria;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Enoxaparin sodium
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Fragmin
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Innohep
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
Tinzaparin sodium
Research, Development & Innovation Department, UHCW NHS Trust
2015 Phase 3 EUCTR2015-002357-35-GB Belgium;Canada;Czech Republic;Denmark;France;Germany;Italy;Lithuania;Netherlands;New Zealand;United Kingdom;United States
